Replies to post #148108 on Biotech Values

[genisi]

I assume they mean they will re-evaluate existing drugs in the clinic as well and that the review is not just strictly related to pre-clinical R&D projects.

You are correct, Teva said all its pipeline will be re-evaluate. They also intend to be more involved in managing projects they partner and share costs. All will be announced on 11/12.